Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Multiple Myeloma × aldesleukin × Clear all

Phase

Status

Completed 7 Recruiting 2 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Ovarian Cancer Metastatic 1 Neoplasms 1 Multiple Myeloma 1 Metastatic HPV-16 Positive Squamous Cell Anal Cancer 1 Metastatic Bladder Urothelial Carcinoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Duodenal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Interventions

Dexamethasone 37 Lenalidomide 17 Melphalan 16 Calcium Dobesilate 16 Bortezomib 15 Cyclophosphamide 9 pomalidomide 8 elotuzumab 7 pembrolizumab 6 fludarabine phosphate 6 carfilzomib 6 ixazomib 5 daratumumab 5 Filgrastim 5 selinexor 4 fludarabine 4 dexamethasone acetate 4 Thalidomide 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 dexamethasone 21-phosphate 3 Whole-Body Irradiation 3 Vorinostat 3 Nivolumab 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 Leukapheresis 3 Granulocyte Colony-Stimulating Factor 3 Ascorbic Acid 3 Arsenic Trioxide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03506802 2020-07-24

NYSCT MM

Jonsson Comprehensive Cancer Center

Phase 1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡